Sunshine Biopharma (SBFM) Share-based Compensation (2010 - 2024)

Sunshine Biopharma's (SBFM) quarterly Share-based Compensation came in at $12000.0 in Q1 2024, down 98.69% on a QoQ basis from $918000.0 in Q1 2021.

Sunshine Biopharma (SBFM) Share-based Compensation (2010 - 2024) Analysis & Trends

Sunshine Biopharma (SBFM) has 13 years of Share-based Compensation data on file, last reported at $12000.0 in Q1 2024.

Quarterly Share-based Compensation changed N/A year-over-year to $12000.0 in Q1 2024, while the trailing twelve-month figure through Dec 2024 was $12000.0 (changed N/A YoY) and the FY2024 annual result came in at $12000.0, changed N/A from the prior year.
Share-based Compensation retreated to $12000.0 in Q1 2024, from $918000.0 in the prior quarter.
In the past five years, Share-based Compensation ranged from a high of $918000.0 in Q1 2021 to a low of $12000.0 in Q1 2024.
A 3-year average of $326666.7 and a median of $50000.0 in 2020 frame the typical range for Share-based Compensation.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Stock Comp. (Qtr)
1	Haleon	43.83 Bn	42.86 Bn	-	-
2	Teva Pharmaceutical Industries	42.87 Bn	39.22 Bn	2.15 Bn	40.00 Mn
3	Zoetis	31.41 Bn	29.73 Bn	1.05 Bn	26.00 Mn
4	Takeda Pharmaceutical	28.55 Bn	22.75 Bn	5.10 Bn	114.12 Mn
5	United Therapeutics	22.08 Bn	19.42 Bn	683.80 Mn	19.00 Mn
6	Viatris	18.73 Bn	17.84 Bn	1.46 Bn	30.40 Mn
7	Neurocrine Biosciences	15.44 Bn	15.05 Bn	935.80 Mn	65.00 Mn
8	Elanco Animal Health	11.75 Bn	11.22 Bn	798.00 Mn	7.00 Mn
9	Dr Reddys Laboratories	10.11 Bn	9.94 Bn	-	-
10	Sunshine Biopharma	1.58 Mn	-12.17 Mn	2.43 Mn	-

Download Data